<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8</volume><submitter>Gabbia D</submitter><funding>Università degli Studi di Padova</funding><pubmed_abstract>Liver fibrosis, which is the outcome of wound-healing response to chronic liver damage, represents an unmet clinical need. This study evaluated the anti-fibrotic and anti-inflammatory effects of the polyphenol oleocanthal (OC) extracted from extra virgin olive oil (EVOO) by an &lt;i>in vitro/in vivo&lt;/i> approach. The hepatic cell lines LX2 and HepG2 were used as &lt;i>in vitro&lt;/i> models. The mRNA expression of pro-fibrogenic markers, namely alpha-smooth muscle actin (α-SMA), collagen type I alpha 1 chain (COL1A1), a panel of metalloproteinases (MMP1, MMP2, MMP3, MMP7, MMP9) and vascular endothelial growth factor A (VEGFA) as well as the pro-oxidant genes NADPH oxidases (NOXs) 1 and 4 were evaluated in TGF-β activated LX2 cells by qRT-PCR. α-SMA and COL1A1 protein expression was assessed by immu</pubmed_abstract><journal>Frontiers in nutrition</journal><pagination>715183</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8521071</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver.</pubmed_title><pmcid>PMC8521071</pmcid><pubmed_authors>Esposito Salsano J</pubmed_authors><pubmed_authors>Russo FP</pubmed_authors><pubmed_authors>Polini B</pubmed_authors><pubmed_authors>Carpi S</pubmed_authors><pubmed_authors>Colognesi M</pubmed_authors><pubmed_authors>Nieri P</pubmed_authors><pubmed_authors>Carrara M</pubmed_authors><pubmed_authors>Sarcognato S</pubmed_authors><pubmed_authors>Digiacomo M</pubmed_authors><pubmed_authors>Guido M</pubmed_authors><pubmed_authors>Manera C</pubmed_authors><pubmed_authors>Scaffidi M</pubmed_authors><pubmed_authors>Macchia M</pubmed_authors><pubmed_authors>Cannella L</pubmed_authors><pubmed_authors>Gabbia D</pubmed_authors><pubmed_authors>De Martin S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver.</name><description>Liver fibrosis, which is the outcome of wound-healing response to chronic liver damage, represents an unmet clinical need. This study evaluated the anti-fibrotic and anti-inflammatory effects of the polyphenol oleocanthal (OC) extracted from extra virgin olive oil (EVOO) by an &lt;i>in vitro/in vivo&lt;/i> approach. The hepatic cell lines LX2 and HepG2 were used as &lt;i>in vitro&lt;/i> models. The mRNA expression of pro-fibrogenic markers, namely alpha-smooth muscle actin (α-SMA), collagen type I alpha 1 chain (COL1A1), a panel of metalloproteinases (MMP1, MMP2, MMP3, MMP7, MMP9) and vascular endothelial growth factor A (VEGFA) as well as the pro-oxidant genes NADPH oxidases (NOXs) 1 and 4 were evaluated in TGF-β activated LX2 cells by qRT-PCR. α-SMA and COL1A1 protein expression was assessed by immu</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-21T14:48:42.415Z</modification><creation>2025-04-21T14:48:42.415Z</creation></dates><accession>S-EPMC8521071</accession><cross_references><pubmed>34671630</pubmed><doi>10.3389/fnut.2021.715183</doi></cross_references></HashMap>